Arrhythmias & electrophysiology
Procedure, management, and outcome of subcutaneous implantable cardioverter–defibrillator extraction in clinical practice
Authors' conclusion
The S-ICD extraction was safe and easy to perform, with no complications.
Study context
- Population
- Patients requiring complete subcutaneous implantable cardioverter-defibrillator (S-ICD) system extraction after de novo S-ICD implantation, 66 Italian centres, 2013–2022of 2718 S-ICD implants
- Participants
- 71 patients
- Outcome
- Procedure, management and outcome of S-ICD extraction
Methodological details66 Italian centres, consecutive patients
- 66 Italian centres
- Consecutive patients
Main finding
As reported in the abstract
S-ICD extraction procedure
Successful extraction in all patients
71
Complications
0
Median procedure duration, min (25th–75th percentile 20-55)
40
Lead removed by simple manual traction
59
84%
Observational data: associations, not effects.
Further findings
| Outcome | P value |
|---|---|
| Lead-dwelling time, simple traction vs others20 (9-32) vs 30 (22-41) months | P = 0.032 |
Hospitalization time
- Non-infectious indications, days
- 2 (1-2)
- Infectious indications, days
- 3 (1-6)
Infection cases (n=17): antibiotics and re-implantation
- Post-extraction IV antibiotics required
- 0
- Median duration of any antibiotic therapy, days
- 10 (10-14)
- Re-implantation during same procedure
- 29%
Safety
Complications during follow-up · median 21 months
- Complications
- 0
Original publication
Procedure, management, and outcome of subcutaneous implantable cardioverter–defibrillator extraction in clinical practice. Europace. Published 23 June 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →